Open AccessDuration of antifungal therapy for septic pulmonary embolism caused by Candida albicans from a central venous catheter: A case report
Author(s) -
Okuno Daisuke,
Oshima Kazuhiro,
Miyazaki Taiga,
Ashizawa Nobuyuki,
Hirayama Tatsuro,
Takazono Takahiro,
Saijo Tomomi,
Yamamoto Kazuko,
Imamura Yoshifumi,
Yamaguchi Hiroyuki,
Sakamoto Noriho,
Obase Yasushi,
Izumikawa Koichi,
Yanagihara Katsunori,
Mukae Hiroshi
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3628
Subject(s) - medicine , candida albicans , central venous catheter , pulmonary embolism , antifungal , lung , intravenous therapy , catheter , bloodstream infection , antibiotics , intensive care medicine , surgery , microbiology and biotechnology , dermatology , biology
The treatment duration for candidemia with septic pulmonary embolism should be determined based on the clearance of fungus from the bloodstream and improvement of symptoms. The remaining lung nodules may not necessarily indicate persistent infection.